SB
Shilpa Bhatia
About Shilpa Bhatia
Data last updated:
Shilpa Bhatia is a Director at Bliss Gvs Pharma Limited (since 2020), Director at Aeroflex Industries Limited (since 2022) and Director at Amj Land Holdings Limited (since 2024). The companies operate in Pharma, Metal & Minerals and Environment. The 3 current companies with reported revenue have a combined latest revenue of ₹1,310 Cr; the largest is Bliss Gvs Pharma Limited at ₹846 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Feb 2020 | 1984 | ₹846 Cr (FY 2025) | Active | |
| Director | 05 Aug 2022 | 1993 | ₹379 Cr (FY 2025) | Active | |
| Director | 01 Nov 2024 | 1964 | ₹85.03 Cr (FY 2025) | Active |
Board colleagues of Shilpa Bhatia
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shilpa Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shilpa Bhatia
Shilpa Bhatia currently holds 3 directorships: Bliss Gvs Pharma Limited (Director, since 11 Feb 2020, revenue ₹846 Cr (FY 2025)); Aeroflex Industries Limited (Director, since 05 Aug 2022, revenue ₹379 Cr (FY 2025)); Amj Land Holdings Limited (Director, since 01 Nov 2024, revenue ₹85.03 Cr (FY 2025)).
Shilpa Bhatia was first appointed on 11 Feb 2020 as Director at Bliss Gvs Pharma Limited. The most recent appointment on record is 01 Nov 2024 at Amj Land Holdings Limited.
The 3 current companies of Shilpa Bhatia that report revenue have a combined latest revenue of ₹1,310 Cr: Bliss Gvs Pharma Limited ₹846 Cr (FY 2025); Aeroflex Industries Limited ₹379 Cr (FY 2025); Amj Land Holdings Limited ₹85.03 Cr (FY 2025).
The current boards of Shilpa Bhatia's companies include Aditi Himanshu Bhatt (Bliss Gvs Pharma Limited), Deepak Bhalchandra Sawant (Bliss Gvs Pharma Limited), Nandkumar Kashinath Chodankar (Bliss Gvs Pharma Limited), Narsimha Shibroor Kamath (Bliss Gvs Pharma Limited), Santosh Laxman Parab (Bliss Gvs Pharma Limited), Shruti Vishal Rao (Bliss Gvs Pharma Limited), among others.